Lexaria receives USD million Australian tax rebate cash payment
Lexaria Bioscience Corp. says it has received a cash tax rebate payment related to its 2025 Australian human study results.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.